Bone Biologics's total assets for Q were $3.19M, a decrease of -16.83% from the previous quarter. BBLG total liabilities were $284.51K for the fiscal quarter, a 72.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.